Abstract
Deficient inhibitory control in Parkinson’s disease (PD) is often observed in situations requiring inhibition of impulsive or prepotent behaviors. Although activation of the right-hemisphere frontal-basal ganglia response inhibition network is partly altered in PD, disturbances in interactions of these regions are poorly understood, especially in patients without cognitive impairment. The present study investigated context-dependent connectivity of response inhibition regions in PD patients with normal cognition and control participants who underwent fMRI while performing a stop signal task. PD participants were tested off antiparkinsonian medication. To determine if functional disturbances depended on underlying brain structure, aberrant connectivity was correlated with brain volume and white-matter tissue diffusivity. We found no group differences in response inhibition proficiency. Yet the PD group showed functional reorganization in the long-range connectivity of inhibition regions, despite preserved within network connectivity. Successful inhibition in PD differed from the controls by strengthened connectivity of cortical regions, namely the right dorsolateral prefrontal cortex, pre-supplementary motor area and right caudal inferior frontal gyrus, largely with ventral and dorsal attention regions, but also the substantia nigra and default mode network regions. Successful inhibition in controls was distinguished by strengthened connectivity of the right rostral inferior frontal gyrus and subcortical inhibition nodes (right caudate, substantia nigra, and subthalamic nucleus). In both groups, the strength of context-dependent connectivity correlated with various indices of response inhibition performance. Mechanisms that may underlie aberrantly stronger context-specific connectivity include reduced coherence within reorganized systems, compensatory mechanisms, and/or the reorganization of intrinsic networks. In PD, but not controls, abnormally strengthened connectivity was linked to individual differences in underlying brain volumes and tissue diffusivity, despite no group differences in structural variables. The pattern of structural-functional associations suggested that subtle decreases in tissue diffusivity of underlying tracts and posterior cortical volumes may undermine the enhancement of normal cortical-striatal connectivity or cause strengthening in cortical-cortical connectivity. These novel findings demonstrate that functionally reorganized interactions of inhibition regions predates the development of inhibition deficits and clinically significant cognitive impairment in PD. We speculate that altered interactions of inhibition regions with attention-related networks and the dopaminergic system may presage future decline in inhibitory control.
Highlights
Executive dysfunction is the most frequently reported cognitive disability in Parkinson’s disease (PD)
Our results demonstrate that functional reorganization of inhibition regions in PD precedes the development of inhibition deficits and clinically significant cognitive impairment
Successful inhibition was related to strengthened connectivity of executive (DLPFC, cIFG) and action planning centers, largely with attentionrelated networks that have been the focus of some behavioral interventions for deficient inhibitory control
Summary
Executive dysfunction is the most frequently reported cognitive disability in Parkinson’s disease (PD). The StN is a key node of a cortical-subcortical right-hemisphere inhibition network, which is comprised of the inferior frontal gyrus (IFG), pre-supplementary motor area (preSMA), primary motor cortex, and basal ganglia [caudate nucleus, substantia nigra (SN)] (Chambers et al, 2009; Wiecki and Frank, 2013; Aron et al, 2014; Morein-Zamir and Robbins, 2015). This network has been widely studied using the stop signal task (SST), which assesses the ability to successfully inhibit a response that is already started to a prepotent Go stimulus. Hypoactivation of the right IFG is most consistently reported in SST studies of PD ON (Ye et al, 2014, 2015, 2016) and de novo PD patients (Vriend et al, 2015), suggesting that decreased activation is unrelated to chronic medication effects
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.